Pathstone Family Office’s HealthEquity HQY Stock Holding History

Pathstone Family Office’s Portfolio HQY Stock Details HQY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$230K	Buy	+3,152	New	+$213K	﹤0.01%	1432
2022 Q4	–	Sell	-6,781	Closed	-$455K	–	1536
2022 Q3	$455K	Buy	+6,781	New	+$429K	﹤0.01%	1114
2021 Q4	–	Sell	-5,322	Closed	-$345K	–	927
2021 Q3	$345K	Buy	5,322 +1,832	+52%	+$127K	0.01%	626
2021 Q2	$281K	Buy	+3,490	New	+$266K	0.01%	669
2019 Q2	–	Sell	-38	Closed	-$3K	–	749
2019 Q1	$3K	Buy	+38	New	+$2.67K	﹤0.01%	690

Other funds holding HQY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pathstone Family Office's HQY Position: Q3 2023 in Review

Pathstone Family Office opened a new position in HealthEquity (HQY) in Q3 2023: 3,152 shares worth $230K. The stake represents ﹤0.01% of the portfolio and ranks #1432 among its holdings. This is a return to the name: Pathstone Family Office previously reported a position in HQY as recently as Q3 2022.

Pathstone Family Office first reported a position in HQY in Q1 2019 and has held it in 5 quarters since. The position peaked at $455K in Q3 2022. 342 funds tracked by Wall St. Rank hold HQY as of Q3 2023.

Pathstone Family Office held 3,152 shares of HealthEquity worth $230K as of Q3 2023.
HealthEquity was a new Pathstone Family Office position in Q3 2023.
HealthEquity made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1432 holding.
Pathstone Family Office first reported a position in HealthEquity in Q1 2019 and has held it in 5 quarters since.
Pathstone Family Office's HealthEquity position peaked at $455K in Q3 2022.
342 funds tracked by Wall St. Rank held HealthEquity as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.